Clinical Trial

Effects of Aquatic Exercise in Older Adults With Sarcopenia:A Randomized Trial

Recruiting
View on ClinicalTrials.gov →
Summary
Sarcopenia is a geriatric syndrome characterized by age-related loss of skeletal muscle mass, strength, and physical performance, leading to increased risk of falls, functional decline, and reduced quality of life. Exercise interventions, particularly resistance training, are effective in managing sarcopenia; however, land-based exercises may be challenging for older adults due to balance impairments, joint problems, and fear of falling. Pool-based exercise programs may offer a safe and feasible alternative, as water buoyancy reduces joint loading while providing resistance to support muscle strengthening. Despite these potential benefits, evidence regarding the effects of aquatic exercise in individuals with sarcopenia remains limited, especially in Türkiye. This study aims to evaluate the effects of a 6-week supervised pool-based exercise program on muscle strength, muscle morphology, physical performance, mood, and quality of life in individuals aged 65 years and older with sarcopenia. Sarcopenia will be identified using the Sonographic Thigh Adjustment Ratio (STAR), based on ultrasound measurements of anterior thigh muscle thickness. In addition, appendicular skeletal muscle mass will be assessed using bioelectrical impedance analysis (ASM/height²). Outcome measures will include ultrasound-based muscle thickness, STAR, muscle strength, functional performance tests, depressive symptoms, and health-related quality of life. Assessments will be performed at baseline, immediately after the intervention, and at 1-month follow-up.
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-07-07
notable Primary completion pushed: 2026-06 -> 2026-08 2026-07-07
minor Completion pushed: 2026-07 -> 2026-08 2026-07-07
Trial Details
NCT Number NCT07575958
Lead Sponsor Gaziosmanpasa Research and Education Hospital
Conditions Sarcopenia, Sarcopenia in Elderly
Enrollment 44 participants
Start Date 2026-04-01
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-06